Literature DB >> 15596586

Aphakic glaucoma after congenital cataract surgery.

Teresa C Chen1, David S Walton, Lini S Bhatia.   

Abstract

OBJECTIVE: To describe the largest series of patients who developed aphakic glaucoma after lensectomy for congenital cataracts.
METHODS: A retrospective review was performed of all patients seen by a pediatric glaucoma specialist between October 1, 1970, and November 30, 2002. Patients with intraocular pressures greater than 25 mm Hg after lensectomy were studied. Patients with either conditions independently associated with glaucoma or any signs of glaucoma before lensectomy were excluded.
RESULTS: We studied 170 eyes of 117 patients. The mean +/- SD follow-up period was 8.6 +/- 7.6 years. The most common cataract types were complete (40.8%) and nuclear (22.5%). For the lensectomies, 103 eyes underwent modern vitrectomy techniques, and 10 underwent older techniques. Lensectomies were performed in 80.6% of eyes before age 1 year. Onset of glaucoma after lensectomy was by 1 year in 37.1% of eyes, by 6 years in 75.9%, and by 33 years in 100%. Of eyes that had gonioscopy, 93.9% had open angles. Glaucoma surgery was needed in 57.1% of eyes. The median final visual acuity was 20/400.
CONCLUSIONS: Most cases of aphakic glaucoma are of the open-angle type. Various risk factors are suggested, and the prognosis is guarded. Lifelong follow-up is needed to screen for glaucoma.

Entities:  

Mesh:

Year:  2004        PMID: 15596586     DOI: 10.1001/archopht.122.12.1819

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  24 in total

1.  [Aphakic and pseudophakic glaucoma following pediatric cataract surgery].

Authors:  A L Solebo; J Rahi; F Grehn
Journal:  Ophthalmologe       Date:  2012-01       Impact factor: 1.059

2.  Prospective analysis of the predictors of glaucoma following surgery for congenital and infantile cataract.

Authors:  Shantha Balekudaru; Sumita Agarkar; Sujatha Guha; Rishikesh Charudatta Mayee; Natarajan Viswanathan; Amit Pandey; Maneesh Singh; Vijaya Lingam; Ronnie George
Journal:  Eye (Lond)       Date:  2018-12-18       Impact factor: 3.775

3.  Glaucoma-Related Adverse Events in the First 5 Years After Unilateral Cataract Removal in the Infant Aphakia Treatment Study.

Authors:  Sharon F Freedman; Michael J Lynn; Allen D Beck; Erick D Bothun; Faruk H Örge; Scott R Lambert
Journal:  JAMA Ophthalmol       Date:  2015-08       Impact factor: 7.389

4.  Glaucoma-related adverse events in the Infant Aphakia Treatment Study: 1-year results.

Authors:  Allen D Beck; Sharon F Freedman; Michael J Lynn; Erick Bothun; Daniel E Neely; Scott R Lambert
Journal:  Arch Ophthalmol       Date:  2011-11-14

5.  Changes of corneal central thickness of aphakia following congenital cataract surgery under the first six months of life.

Authors:  Wei Xiao; Xiao-Fang Liang; Jia-Jun Sun
Journal:  Int J Ophthalmol       Date:  2011-02-18       Impact factor: 1.779

6.  Glaucoma and increased central corneal thickness in aphakic and pseudophakic patients after congenital cataract surgery.

Authors:  T Simsek; A H Mutluay; U Elgin; R Gursel; A Batman
Journal:  Br J Ophthalmol       Date:  2006-05-17       Impact factor: 4.638

7.  Risk factors for the development of aphakic glaucoma after congenital cataract surgery.

Authors:  Teresa C Chen; Lini S Bhatia; Elkan F Halpern; David S Walton
Journal:  Trans Am Ophthalmol Soc       Date:  2006

8.  Secondary glaucoma after paediatric cataract surgery.

Authors:  B N Swamy; F Billson; F Martin; C Donaldson; S Hing; R Jamieson; J Grigg; J E H Smith
Journal:  Br J Ophthalmol       Date:  2007-05-02       Impact factor: 4.638

Review 9.  Advances in the management of the surgical complications for congenital cataract.

Authors:  Fangqin Ma; Qi Wang; Lihua Wang
Journal:  Front Med       Date:  2012-12-07       Impact factor: 4.592

10.  [23-gauge-lentectomy for the treatment of congenital cataract].

Authors:  P Meier; I Sterker; H Tegetmeyer; P Wiedemann
Journal:  Ophthalmologe       Date:  2010-03       Impact factor: 1.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.